Guardant Health (GH) Common Equity (2017 - 2026)

Guardant Health has disclosed Common Equity across 10 years of filings, most recently posting -$222.9 million for Q2 2026.

• In Q2 2026, Common Equity rose 27.04% year-over-year to -$222.9 million; the TTM figure through Jun 2026 stood at -$222.9 million (up 27.04% YoY), while the FY2025 annual figure was -$99.3 million, up 28.89% from the prior year.
• Common Equity came in at -$222.9 million for Q2 2026 at Guardant Health, down from -$181.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $533.0 million in Q1 2022 to a low of -$354.5 million in Q3 2025.
• Average Common Equity over 5 years is $9.3 million, with a median of -$23.1 million recorded in 2023.
• Year-over-year, Common Equity surged 253.27% in 2024 and sank 18838.31% in 2025.
• Over 5 years, Common Equity stood at $60.2 million in 2022, then surged by 163.68% to $158.7 million in 2023, then slumped by 188.0% to -$139.6 million in 2024, then advanced by 28.89% to -$99.3 million in 2025, then slumped by 124.42% to -$222.9 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$222.9 million in Q2 2026, -$181.1 million in Q1 2026, and -$99.3 million in Q4 2025.